Gefitinib — a novel targeted approach to treating cancer
Top Cited Papers
- 1 December 2004
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 4 (12) , 956-965
- https://doi.org/10.1038/nrc1506
Abstract
Twenty years after the epidermal growth factor receptor (EGFR) was identified as a potential anticancer target, the EGFR inhibitor gefitinib (Iressa; AstraZeneca) has been approved for the treatment of patients with advanced non-small-cell lung cancer in many countries. Studies have indicated its potential for treating patients with other types of solid tumours. Investigation of gefitinib has not only increased our knowledge about the biology of EGFR signalling, but is contributing to our evolving understanding of which tumours are EGFR dependent.Keywords
This publication has 51 references indexed in Scilit:
- Status of Epidermal Growth Factor Receptor Antagonists in the Biology and Treatment of CancerJournal of Clinical Oncology, 2003
- Co-expression of epidermal growth factor receptor and transforming growth factor-α predicts worse prognosis in breast-cancer patientsInternational Journal of Cancer, 2000
- The Hallmarks of CancerCell, 2000
- Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trialInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Phase I and Imaging Trial of Indium 111-Labeled Anti-Epidermal Growth Factor Receptor Monoclonal Antibody 225 in Patients With Squamous Cell Lung CarcinomaJNCI Journal of the National Cancer Institute, 1991
- Over‐expression of the EGF receptor is a hallmark of squamous cell carcinomasThe Journal of Pathology, 1986
- Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.Proceedings of the National Academy of Sciences, 1983
- Autocrine Secretion and Malignant Transformation of CellsNew England Journal of Medicine, 1980
- Isolation and structure of urogastrone and its relationship to epidermal growth factorNature, 1975
- Human epidermal growth factor: isolation and chemical and biological properties.Proceedings of the National Academy of Sciences, 1975